(intention to treat analysis[mesh] OR placebos[mesh] OR placebo effect[mesh] OR controlled clinical trial[mesh] OR random allocation[mesh] OR dna shuffling[mesh] OR trial[Title/Abstract] OR groups[Title/Abstract] OR Randomized Controlled Trial[Publication Type] OR Controlled Clinical Trial[Publication Type] OR placebo[Title/Abstract] OR randomly[Title/Abstract] OR (randomized[Title/Abstract] OR randomised[Title/Abstract])) AND (edema[mesh] OR choroid[mesh] OR syndrome[mesh] OR macular degeneration[mesh] OR contingent negative variation[mesh] OR retinal diseases[mesh] OR choroidal neovascularization[mesh] OR retina[mesh] OR cyclophosphamide[mesh] OR antineoplastic combined chemotherapy protocols[mesh] OR vincristine[mesh] OR heterocyclic compounds, 1-ring[mesh] OR heterocyclic compounds[mesh] OR etoposide[mesh] OR neovascularization, physiologic[mesh] OR mitoxantrone[mesh] OR muscular dystrophy, facioscapulohumeral[mesh] OR Maculopath*[Text Word] OR (neovasc*[Text Word] AND (macul*[Text Word] OR retina*[Text Word] OR choroid*[Text Word])) OR (macul*[Text Word] AND dystroph*[Text Word]) OR (atroph*[Text Word] AND (macul*[Text Word] OR geographic[Text Word])) OR (edema*[Text Word] AND (macul*[Text Word] OR retina*[Text Word])) OR (AMD[Text Word] OR ARMD[Text Word] OR CNV[Text Word]) OR (degener*[Text Word] AND (macul*[Text Word] OR retina*[Text Word] OR choroid*[Text Word])) OR (macul*[Text Word] AND lutea*[Text Word]) OR (macul*[Text Word] AND syndrome[Text Word])) AND (antigens, differentiation, t-lymphocyte[mesh] OR granuloma, plasma cell[mesh] OR IMT*[Text Word] OR Prosthe*[Text Word] OR Telescop*[Text Word] OR microtelescop*[Text Word])